FDA considering regulation of surgical instrument marking tape; survey of operating room nurses proposed.
This article was originally published in The Gray Sheet
SURGICAL MARKING TAPE: FDA REGULATION UNDER CONSIDERATION by the agency due to concern about adverse event reports associated with the product. Four adverse events have been reported with the adhesive-backed colored tape, used to color-code surgical instruments.
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.